Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2002 Nov;61(Suppl 2):ii40–ii42. doi: 10.1136/ard.61.suppl_2.ii40

Functions of AP1 (Fos/Jun) in bone development

E Wagner
PMCID: PMC1766713  PMID: 12379619

Full Text

The Full Text of this article is available as a PDF (97.1 KB).

Figure 1 .

Figure 1

Open in a new tab

Signalling in osteoclast progenitor cells and cross talk with the interferon pathway. For details see also Karsenty and Wagner4).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Behrens Axel, Sibilia Maria, David Jean-Pierre, Möhle-Steinlein Uta, Tronche François, Schütz Günther, Wagner Erwin F. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J. 2002 Apr 2;21(7):1782–1790. doi: 10.1093/emboj/21.7.1782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fleischmann A., Hafezi F., Elliott C., Remé C. E., Rüther U., Wagner E. F. Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev. 2000 Nov 1;14(21):2695–2700. doi: 10.1101/gad.187900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Grigoriadis A. E., Schellander K., Wang Z. Q., Wagner E. F. Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol. 1993 Aug;122(3):685–701. doi: 10.1083/jcb.122.3.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Grigoriadis A. E., Wang Z. Q., Cecchini M. G., Hofstetter W., Felix R., Fleisch H. A., Wagner E. F. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science. 1994 Oct 21;266(5184):443–448. doi: 10.1126/science.7939685. [DOI] [PubMed] [Google Scholar]
  5. Jain J., Nalefski E. A., McCaffrey P. G., Johnson R. S., Spiegelman B. M., Papaioannou V., Rao A. Normal peripheral T-cell function in c-Fos-deficient mice. Mol Cell Biol. 1994 Mar;14(3):1566–1574. doi: 10.1128/mcb.14.3.1566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jochum W., Passegué E., Wagner E. F. AP-1 in mouse development and tumorigenesis. Oncogene. 2001 Apr 30;20(19):2401–2412. doi: 10.1038/sj.onc.1204389. [DOI] [PubMed] [Google Scholar]
  7. Johnson R. S., Spiegelman B. M., Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell. 1992 Nov 13;71(4):577–586. doi: 10.1016/0092-8674(92)90592-z. [DOI] [PubMed] [Google Scholar]
  8. Karsenty Gerard, Wagner Erwin F. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002 Apr;2(4):389–406. doi: 10.1016/s1534-5807(02)00157-0. [DOI] [PubMed] [Google Scholar]
  9. Matsuo K., Owens J. M., Tonko M., Elliott C., Chambers T. J., Wagner E. F. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet. 2000 Feb;24(2):184–187. doi: 10.1038/72855. [DOI] [PubMed] [Google Scholar]
  10. McCabe L. R., Banerjee C., Kundu R., Harrison R. J., Dobner P. R., Stein J. L., Lian J. B., Stein G. S. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation. Endocrinology. 1996 Oct;137(10):4398–4408. doi: 10.1210/endo.137.10.8828501. [DOI] [PubMed] [Google Scholar]
  11. Okada S., Wang Z. Q., Grigoriadis A. E., Wagner E. F., von Rüden T. Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment. Mol Cell Biol. 1994 Jan;14(1):382–390. doi: 10.1128/mcb.14.1.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Owens J. M., Matsuo K., Nicholson G. C., Wagner E. F., Chambers T. J. Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines. J Cell Physiol. 1999 May;179(2):170–178. doi: 10.1002/(SICI)1097-4652(199905)179:2<170::AID-JCP7>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  13. Sabatakos G., Sims N. A., Chen J., Aoki K., Kelz M. B., Amling M., Bouali Y., Mukhopadhyay K., Ford K., Nestler E. J. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med. 2000 Sep;6(9):985–990. doi: 10.1038/79683. [DOI] [PubMed] [Google Scholar]
  14. Sabatakos G., Sims N. A., Chen J., Aoki K., Kelz M. B., Amling M., Bouali Y., Mukhopadhyay K., Ford K., Nestler E. J. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med. 2000 Sep;6(9):985–990. doi: 10.1038/79683. [DOI] [PubMed] [Google Scholar]
  15. Sandberg M., Vuorio T., Hirvonen H., Alitalo K., Vuorio E. Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones. Development. 1988 Mar;102(3):461–470. doi: 10.1242/dev.102.3.461. [DOI] [PubMed] [Google Scholar]
  16. Schreiber M., Wang Z. Q., Jochum W., Fetka I., Elliott C., Wagner E. F. Placental vascularisation requires the AP-1 component fra1. Development. 2000 Nov;127(22):4937–4948. doi: 10.1242/dev.127.22.4937. [DOI] [PubMed] [Google Scholar]
  17. Shaulian Eitan, Karin Michael. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002 May;4(5):E131–E136. doi: 10.1038/ncb0502-e131. [DOI] [PubMed] [Google Scholar]
  18. Takayanagi Hiroshi, Kim Sunhwa, Matsuo Koichi, Suzuki Hiroshi, Suzuki Tomohiko, Sato Kojiro, Yokochi Taeko, Oda Hiromi, Nakamura Kozo, Ida Nobutaka. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature. 2002 Apr 18;416(6882):744–749. doi: 10.1038/416744a. [DOI] [PubMed] [Google Scholar]
  19. Thomas D. P., Sunters A., Gentry A., Grigoriadis A. E. Inhibition of chondrocyte differentiation in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene. J Cell Sci. 2000 Feb;113(Pt 3):439–450. doi: 10.1242/jcs.113.3.439. [DOI] [PubMed] [Google Scholar]
  20. Wagner E. F., Karsenty G. Genetic control of skeletal development. Curr Opin Genet Dev. 2001 Oct;11(5):527–532. doi: 10.1016/s0959-437x(00)00228-8. [DOI] [PubMed] [Google Scholar]
  21. Wang Z. Q., Grigoriadis A. E., Möhle-Steinlein U., Wagner E. F. A novel target cell for c-fos-induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras. EMBO J. 1991 Sep;10(9):2437–2450. doi: 10.1002/j.1460-2075.1991.tb07783.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wang Z. Q., Kiefer F., Urbánek P., Wagner E. F. Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection. Mech Dev. 1997 Mar;62(2):137–145. doi: 10.1016/s0925-4773(97)00655-2. [DOI] [PubMed] [Google Scholar]
  23. Wang Z. Q., Ovitt C., Grigoriadis A. E., Möhle-Steinlein U., Rüther U., Wagner E. F. Bone and haematopoietic defects in mice lacking c-fos. Nature. 1992 Dec 24;360(6406):741–745. doi: 10.1038/360741a0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES